Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to assess the role of lymphoscintigraphy as a simple and widely accessible method with a favorable cost/benefit ratio in improving oral cavity and oropharyngeal squamous cell carcinoma staging and surgical appropriateness and implementing a tailored surgical approach to cervical lymph node dissection.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03727594
Study type Observational
Source University Hospital of Ferrara
Contact Nicola Malagutti, MD
Phone +393339011406
Email nicolamalagutti@gmail.com
Status Recruiting
Phase
Start date January 2016
Completion date January 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06174428 - Validity of Viome's Oral/Throat Cancer Test
Recruiting NCT05098119 - Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002) Phase 2
Suspended NCT03952585 - De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer Phase 2/Phase 3
Terminated NCT03618134 - Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner Phase 1/Phase 2
Recruiting NCT03421470 - Docetaxel and Radiation Therapy in Treating Patients With HPV Positive Oropharynx Cancer Phase 3
Completed NCT06314711 - Ex Vivo 3D-ultrasound for Oropharyngeal Cancer N/A
Completed NCT04572100 - Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer Phase 1
Not yet recruiting NCT06055868 - People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Recruiting NCT05522881 - The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan
Recruiting NCT04222543 - Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging Phase 2
Recruiting NCT04564989 - Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Active, not recruiting NCT04965792 - Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Recruiting NCT06356272 - Oropharynx (OPX) Biomarker Trial
Active, not recruiting NCT01874171 - Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC Phase 3
Recruiting NCT05333523 - Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study. Phase 3
Completed NCT03618654 - Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma Early Phase 1
Recruiting NCT04801472 - Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM) N/A
Active, not recruiting NCT03410615 - Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC Phase 2
Recruiting NCT05268614 - Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma Phase 2
Not yet recruiting NCT05582590 - Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers Phase 1